AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ)
$19.29 -0.28 (-1.4308%)
Analysed AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) News Sources
Does Amneal’s Post‑Earnings Shelf Registration Reshape the Bull Case for Amneal Pharmaceuticals (AMRX)?
05-09-2026
yahoo.com
Amneal (AMRX) Surges 8.6%: Is This an Indication of Further Gains?
17-09-2026
yahoo.com
3 Reasons to Avoid AMRX and 1 Stock to Buy Instead
18-09-2026
yahoo.com
Amneal Announces FDA Approval and Launch of Lanreotide Injection
18-09-2026
yahoo.com
Why Is Amneal (AMRX) Stock Rocketing Higher Today
22-09-2026
yahoo.com
Amneal Pharmaceuticals (AMRX) Stock Gets Fair Value Bump After Analyst Backing For New Launches
03-10-2026
yahoo.com
3 Low-Volatility Stocks with Open Questions
05-10-2026
yahoo.com
Amneal to Report Third Quarter 2026 Results on November 3, 2026
08-10-2026
yahoo.com
3 Overrated Stocks We Think Twice About
09-10-2026
yahoo.com
1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds
13-10-2026
yahoo.com
What is the current price of AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ)?
The current price of AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) is $19.29.
AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) since the previous trading day is $-0.28.
AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) since the previous trading day is -1.4308%.
What is the most recent average sentiment score for AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ)?
The most recent average sentiment score for AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) is 51 out of 100.
What is the most recent average sentiment for AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ)?
The most recent sentiment for AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ) is .
SEC-8K** Filing Available For AMNEAL PHARMACEUTICALS INC (AMRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.